Human Genome Epidemiology Literature Finder
|
Records 1 - 13 (of 13 Records) |
| Query Trace: Cardiovascular Diseases and CYP2C9[original query] |
|---|
| Allelic variants of cytochromes P450 2C modify the risk for acute myocardial infarction. Pharmacogenetics 2003 Dec 13 (12): 715-20. Yasar Umit, Bennet Anna M, Eliasson Erik, Lundgren Stefan, Wiman Björn, De Faire Ulf, Rane Ande |
| Thrombotic genetic risk factors and warfarin pharmacogenetic variants in São Miguel's healthy population (Azores). Thrombosis journal 2009 7 . Branco CC, Pereirinha T, Cabral R, Pacheco PR, Mota-Vieira L |
| The preventive factors for aspirin-induced peptic ulcer: aspirin ulcer and corpus atrophy. Journal of gastroenterology 2009 44 (7): 717-25. Shiotani Akiko, Sakakibara Takashi, Yamanaka Yoshiyuki, Nishi Ryuji, Imamura Hiroshi, Fujita Minoru, Tarumi Ken-ichi, Kamada Tomoari, Hata Jiro, Haruma K |
| Frequencies of 23 functionally significant variant alleles related with metabolism of antineoplastic drugs in the chilean population: comparison with caucasian and asian populations. Frontiers in genetics 2012 3 . Roco A, Quiñones L, Agúndez JA, García-Martín E, Squicciarini V, Miranda C, Garay J, Farfán N, Saavedra I, Cáceres D, Ibarra C, Varela N |
| Warfarin anticoagulant therapy: a Southern Italy pharmacogenetics-based dosing model. PloS one 2013 8 (8): e71505. Mazzaccara Cristina, Conti Valeria, Liguori Rosario, Simeon Vittorio, Toriello Mario, Severini Angelo, Perricone Corrado, Meccariello Alfonso, Meccariello Pasquale, Vitale Dino Franco, Filippelli Amelia, Sacchetti Luc |
| [CLINICAL AND PHARMACOLOGICAL FACTORS INFLUENCING RESISTANCE TO CLOPIDOGREL IN PATIENTS WITH CARDIOVASCULAR DISEASES]. Klinicheskaia meditsina 2015 93 (2): 40-6. Mesitskaia D F, Nikitina Iu M, Kopylov F Iu, Syrkin A L, Aksenova M G, Kirillov M Iu, Dobrovol'ski? A |
| Association of CYP2C8, CYP2C9 and CYP2J2 gene polymorphisms with myocardial infarction in South Indian population. Pharmacological reports : PR 2015 Feb 67 (1): 97-101. Arun Kumar Annan Sudarsan, Kumar Srinivasamurthy Suresh, Umamaheswaran Gurusamy, Kesavan Ramasamy, Balachandar Jayaraman, Adithan Chandrasekar |
| Impact of CYP2C9 and VKORC1 Polymorphisms on Warfarin Sensitivity and Responsiveness in Jordanian Cardiovascular Patients during the Initiation Therapy. Genes 2018 11 9 (12): . Al-Eitan Laith N, Almasri Ayah Y, Khasawneh Rame |
| A Pharmacogenetically Guided Acenocoumarol Dosing Algorithm for Chilean Patients: A Discovery Cohort Study. Frontiers in pharmacology 2020 4 11 325. Roco Angela, Nieto Elena, Suárez Marcelo, Rojo Mario, Bertoglia Maria Paz, Verón Gabriel, Tamayo Francisca, Arredondo Annabella, Cruz Daniela, Muñoz Jessica, Bravo Gabriela, Salas Patricio, Mejías Fanny, Godoy Gerald, Véliz Paulo, Quiñones Luis Ab |
| A Pharmacogenomic Dissection of a Rosuvastatin-Induced Rhabdomyolysis Case Evokes the Polygenic Nature of Adverse Drug Reactions. Pharmacogenomics and personalized medicine 2020 3 13 59-70. Calderon-Ospina Carlos Alberto, Hernández-Sómerson Mario, García Ana María, Mejia Adriana, Tamayo-Agudelo Caroll, Laissue Paul, Fonseca Mendoza Dora Jane |
| Assessment of pharmacogenomic SLCO1B1 assay for prediction of neuromuscular pain in type 2 diabetes mellitus and cardiovascular patients: preliminary results. European review for medical and pharmacological sciences 2020 Jan 24 (1): 469-477. Licito A, Marotta G, Battaglia M, Benincasa G, Mentone L, Grillo M R, De Lucia V, Leonardi G, Bignucolo A, Comello F, Di Francia R, De Lucia |
| Cardiovascular Pharmacogenomics: An Update on Clinical Studies of Antithrombotic Drugs in Brazilian Patients. Molecular diagnosis & therapy 2021 8 25 (6): 735-755. Hirata Thiago Dominguez Crespo, Dagli-Hernandez Carolina, Genvigir Fabiana Dalla Vecchia, Lauschke Volker Martin, Zhou Yitian, Hirata Mario Hiroyuki, Hirata Rosario Dominguez Cres |
| Biochip-based approach for comprehensive pharmacogenetic testing. Drug metabolism and personalized therapy 2020 Dec . Ikonnikova Anna Yu, Filippova Marina A, Surzhikov Sergey A, Pozhitnova Victoria O, Kazakov Ruslan E, Lisitsa Tatiana S, Belkov Sergey A, Nasedkina Tatiana |
- Page last reviewed:Feb 1, 2023
- Page last updated:Sep 25, 2023
- Content source: